Navigation and service

Guidance for occupational physicians and health and safety professionals in the treatment of beryllium exposure

Project number: F 2061 Institution: Federal Institute for Occupational Safety and Health (BAuA) Status: Completed Project


Chronic beryllium disease (CBD) is a granulomatous disorder and a perfect pheno-copy of sarcoidosis. Therefore misdiagnoses are easily possible. Germany has no uniform recommendations as to how occupational CBD should be diagnosed. A guideline for a standardised diagnostic procedure and a checklist with questions on typical occupational beryllium exposures are going to be developed for physicians.



Unit 3.5 "Evidence-based Occupational Health, Workplace Health Management"

Phone: +49 231 9071-1971 Fax: +49 231 9071-2070

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy